Epilepsy Pharmaceutical Policy Treatment 
Cannabis Law Report
JULY 30, 2019
Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. Knowledge, attitudes and policies regarding medical cannabis and cannabis-based drugs are changing. Cannabidiol-based treatment receives marketing approval from EMA.
Veriheal
FEBRUARY 21, 2023
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Why Do MMJ Patients Use Cannabis?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaTech
AUGUST 9, 2018
We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).
Burns Levinson (Cannabusiness advisory)
OCTOBER 3, 2018
On June 25, 2018, the Food and Drug Administration announced that it approved the drug Epidiolex for the treatment of seizures in connection with epilepsy. Under the CSA, CBD remains a Schedule I substance, which means that it is not considered to have any currently accepted medical use. While … Keep reading.
The Cannigma
OCTOBER 20, 2021
Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. believe that medical cannabis is a legitimate treatment option and that 86% see it as a therapeutic agent for treating cancer and chemotherapy-induced side effects.
Cannabis Law Report
NOVEMBER 22, 2019
In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition.
Expert insights. Personalized for you.
40 
Let's personalize your content